Serum Cystatin C as an Endogenous Marker of Renal Function in Patients with Chronic Kidney Disease (CKD)

Authors

  • Md Anwarul Haque Faraji Assistant Professor, Department of Nephrology, National Institute of Kidney Diseases & Urology, Dhaka
  • Mohammed Rashed Anwar Assistant Professor, Department of Nephrology, National Institute of Kidney Diseases & urology, Dhaka
  • Dilip Kumar Debnath Assistant Professor, Department of Nephrology, National Institute of Kidney Diseases & Urology, Dhaka
  • Md Babrul Alam Associate Professor, Department of Nephrology, National Institute of Kidney Diseases & urology, Dhaka
  • Syed Mahbub Morshed Assistant Professor, Department of Nephrology, Shaheed Suhrawardy medical College, Dhaka
  • KAM Mahbub Hasan Medical Officer, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka

DOI:

https://doi.org/10.3329/jcamr.v4i1.36168

Keywords:

Cystatin C, CKD, Endogenous Marker, Renal Function

Abstract

Background: Cystatin C is being considered as a potential replacement for serum creatinine as a filtration marker.

Objectives: This present study was conducted to determine the validity of Cystatin C as a renal function test and to compare the Cystatin C and serum creatinine level between the CKD cases and person not having CKD.

Methodology: The present case control study was conducted in the department of Nephrology of Dhaka Medical College Hospital during the period of January 2009 to December 2009 with the aim to find out the serum Cystatin C as diagnostic markers of chronic kidney disease. In the present study total 100 respondents were included. Among them 50 were CKD patients and another 50 were without CKD. 

Results: It was an age and sex matched study. Out of 50 patients with CKD, 29 (58.0%) were in the stage IV followed by 15 (30.0%) were in the stage III and rest 6 (12.0%) were in the stage V. In CKD group 31 (62.0%) had glomerulonephritis, 18 (36.0%) had HTN, 11 (22.0%) had DM and 3 (6.0%) had obstructive uropathy.  In without CKD group 9 (18.0%) had HTN, 6 (12.0%) had DM. Mean±SD of Serum Creatinine in CKD and without CKD groups were 5.73±2.69 and 0.85±0.11mg/dl respectively. Mean±SD of Serum Cystatin C in CKD and without CKD groups were 3.59±1.21 and 0.71±0.09 mg/dl respectively. In all patients sensitivity of Cystatin C to diagnose CKD was 100.0% and specificity also100.0%. Sensitivity of serum creatinine to diagnose CKD was 88.0% and specificity was 100.0%.

Conclusions: Cystatin C proved more reliable than creatinine and was comparable to plasma creatinine and Cockcroft-Gault estimation. Serum Cystatin C had higher diagnostic accuracy with high sensitivity and specificity to detect renal function and is a reliable marker of renal function.

Journal of Current and Advance Medical Research 2017;4(1):3-12

Downloads

Download data is not yet available.
Abstract
9
PDF
9

Downloads

Published

2018-04-05

How to Cite

Faraji, M. A. H., Anwar, M. R., Debnath, D. K., Alam, M. B., Morshed, S. M., & Hasan, K. M. (2018). Serum Cystatin C as an Endogenous Marker of Renal Function in Patients with Chronic Kidney Disease (CKD). Journal of Current and Advance Medical Research, 4(1), 3–12. https://doi.org/10.3329/jcamr.v4i1.36168

Issue

Vol. 4 No. 1 (2017)

Section

Original Articles

License

Copyright on any research article in the Journal of Current and Advance Medical Research is retained by the author(s).

The authors grant the Journal of Current and Advance Medical Research a license to publish the article and identify itself as the original publisher.

Articles in the Journal of Current and Advance Medical Research are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.